Generation of epidermal growth factor-expressing Lactococcus lactis and its enhancement on intestinal development and growth of early-weaned mice

American Journal of Clinical Nutrition

Volumn 89, Issue 3, 2009, Pages 871-879

  Cheung, Queenie C K ^a   Yuan, Zongfei ^a   Dyce, Paul W ^a   De Wu, ^b   Delange, Kees ^a   Li, Julang ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b SICHUAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; EPIDERMAL GROWTH FACTOR; PHOSPHATE BUFFERED SALINE; PROBIOTIC AGENT; RECOMBINANT EPIDERMAL GROWTH FACTOR;

ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL COUNT; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTESTINE; INTESTINE CELL; INTESTINE CRYPT; INTESTINE VILLUS; LACTOCOCCUS LACTIS; MALE; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; WEANING; WEIGHT GAIN;

ANIMALS; BLOTTING, WESTERN; CELL GROWTH PROCESSES; CLONING, MOLECULAR; EPIDERMAL GROWTH FACTOR; FECES; FEMALE; GASTROINTESTINAL TRACT; IMMUNOHISTOCHEMISTRY; LACTOCOCCUS LACTIS; MALE; MICE; RANDOM ALLOCATION;

LACTOCOCCUS LACTIS; MUS;

EID: 61449264653     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2008.27073     Document Type: Article

References (48)

1. Kelly D, Smyth JA, McCracken KJ. Digestive development of the early-weaned pig. 2. Effect of level of food intake on digestive enzyme activity during the immediate post-weaning period. Br J Nutr 1991;65: 181-8.
2. Gu X, Li D, She R. Effect of weaning on small intestinal structure and function in the piglet. Arch Tierernahr 2002;56:275-86.
3. Cohen S. The stimulation of epidermal proliferation by a specific protein (EGF). Dev Biol 1965;12:394-407.
4. Burgess AW. Epidermal growth factor and transforming growth factor alpha. Br Med Bull 1989;45:401-24.
5. Jaeger LA, Lamar CH, Cline TR, Cardona CJ. Effect of orally administered epidermal growth factor on the jejunal mucosa of weaned pigs. Am J Vet Res 1990;51:471-4.
6. Barnard JA, Beauchamp RD, Russell WE, Dubois RN, Coffey RJ. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 1995;108:564-80.
7. Playford RJ, Wright NA. Why is epidermal growth factor present in the gut lumen? Gut 1996;38:303-5.
8. Buchmiller TL, Shaw KS, Chopourian HL, et al. Effect of transamniotic administration of epidermal growth factor on fetal rabbit small intestinal nutrient transport and disaccharidase development. J Pediatr Surg 1993; 28:1239-44.
9. Ulshen MH, Lyn-Cook LE, Raasch RH. Effects of intraluminal epidermal growth factor on mucosal proliferation in the small intestine of adult rats. Gastroenterology 1986;91:1134-40.
10. James PS, Smith MW, Tivey DR, Wilson TJ. Epidermal growth factor selectively increases maltase and sucrase activities in neonatal piglet intestine. J Physiol 1987;393:583-94.
11. Buret A, Olson ME, Gall DG, Hardin JA. Effects of orally administered epidermal growth factor on enteropathogenic Escherichia coli infection in rabbits. Infect Immun 1998;66:4917-23.
12. Buret AG, Chin AC, Scott KG. Infection of human and bovine epithelial cells with Cryptosporidium andersoni induces apoptosis and disrupts tight junctional ZO-1: effects of epidermal growth factor. Int J Parasitol 2003;33:1363-71.
13. Buret AG, Mitchell K, Muench DG, Scott KG. Giardia lamblia disrupts tight junctional ZO-1 and increases permeability in non-transformed human small intestinal epithelial monolayers: effects of epidermal growth factor. Parasitology 2002;125:11-9.
14. Donovan SM, Zijlstra RT, Odle J. Use of the piglet to study the role of growth factors in neonatal intestinal development. Endocr Regul 1994; 28:153-62.
15. Drouault S, Corthier G, Ehrlich SD, Renault P. Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl Environ Microbiol 1999;65:4881-6.
16. Frossard CP, Steidler L, Eigenmann PA. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization. J Allergy Clin Immunol 2007;119:952-9.
17. Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000;289:1352-5.
18. Steidler L, Neirynck S, Huyghebaert N, et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 2003;21:785-9.
19. Kim JG, Vallet JL, Christenson RK. Characterization of uterine epidermal growth factor during early pregnancy in pigs. Domest Anim Endocrinol 2001;20:253-65.
20. Madsen SM, Arnau J, Vrang A, Givskov M, Israelsen H. Molecular characterization of the pH-inducible and growth phase-dependent promoter P170 of Lactococcus lactis. Mol Microbiol 1999;32:75-87.
21. Campbell TN, Choy FY. Large-scale colony screening and insert orientation determination using PCR. Biotechniques 2001;30:32-4.
22. Linher K, Wu D, Li J. Glial cell line-derived neurotrophic factor: an intraovarian factor that enhances oocyte developmental competence in vitro. Endocrinology 2007;148:4292-301.
23. Muskhelishvili L, Latendresse JR, Kodell RL, Henderson EB. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. J Histochem Cytochem 2003;51:1681-8.
24. Playford RJ, Hanby AM, Gschmeissner S, Peiffer LP, Wright NA, McGarrity T. The epidermal growth factor receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract. Gut 1996;39:262-6.
25. Thompson JF. Specific receptors for epidermal growth factor in rat intestinal microvillus membranes. Am J Physiol 1988;254:G429-35.
26. Kelly D, McFadyen M, King TP, Morgan PJ. Characterization and autoradiographic localization of the epidermal growth factor receptor in the jejunum of neonatal and weaned pigs. Reprod Fertil Dev 1992;4: 183-91.
27. Wallace LE, Hardin JA, Gall DG. Expression of EGF and erbB receptor proteins in small intestinal epithelium. Can J Gastroenterol 2001;15(suppl SA) (abstr 135).
28. Thompson JF, van den Berg M, Stokkers PC. Developmental regulation of epidermal growth factor receptor kinase in rat intestine. Gastroen-terology 1994;107:1278-87.
29. Miettinen PJ, Perheentupa J, Otonkoski T, Lahteenmaki A, Panula P. EGF-and TGF-alpha-like peptides in human fetal gut. Pediatr Res 1989; 26:25-30.
30. Upperman JS, Potoka D, Grishin A, Hackam D, Zamora R, Ford HR. Mechanisms of nitric oxide-mediated intestinal barrier failure in nec-rotizing enterocolitis. Semin Pediatr Surg 2005;14:159-66.
31. Abud HE, Watson N, Heath JK. Growth of intestinal epithelium in organ culture is dependent on EGF signalling. Exp Cell Res 2005;303:252-62.
32. Bashir O, Fitzgerald AJ, Berlanga-Acosta J, Playford RJ, Goodlad RA. Effect of epidermal growth factor administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice. Clin Sci (Lond) 2003;105:323-30.
33. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001;291:881-4.
34. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002;22:283-307.
35. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003;52:988-97.
36. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 2004;28:405-40.
37. Vaughan EE, de Vries MC, Zoetendal EG, Ben-Amor K, Akkermans AD, de Vos WM. The intestinal LABs. Antonie Van Leeuwenhoek 2002; 82:341-52.
38. Hudault S, Lievin V, Bernet-Camard MF, Servin AL. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 1997;63:513-8.
39. Servin AL, Coconnier MH. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol 2003;17:741-54.
40. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of pro-biotics in clinical practice. Clin Microbiol Rev 2003;16:658-72.
41. Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005;115:5-9.
42. Doyle M. Alternatives to antibiotic use for growth promotion in animal husbandry. FRI Briefings: Food Research Institute. Madison, WI: University of Wisconsin, 2001.
43. Kremer B. DFM products provide consistent outcomes: producers look for consistently performing feed additives, and research has found that certain direct-fed microbial products can fit this description (direct-fed microbials). Feedstuffs April 24, 2006. Available from: http://www.accessmylibrary.com/coms2/ browse-JJ-.
44. Mierau I, Kleerebezem M. 10 Years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Bio-technol 2005;68:705-17.
45. Steidler L, Rottiers P. Therapeutic drug delivery by genetically modified Lactococcus lactis. Ann N Y Acad Sci 2006;1072:176-86.
46. Steidler L, Wells JM, Raeymaekers A, Vandekerckhove J, Fiers W, Remaut E. Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis. Appl Environ Microbiol 1995;61: 1627-9.
47. Shin CE, Helmrath MA, Falcone RA Jr, et al. Epidermal growth factor augments adaptation following small bowel resection: optimal dosage, route, and timing of administration. J Surg Res 1998;77:11-6.
48. Klijn N, Weerkamp AH, de Vos WM. Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl Environ Microbiol 1995;61:2771-4.